Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Research and development spending
3Y CAGR
+68.6%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
4.8x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $136.21M | +21.1% |
| 2024 | $112.47M | +133.3% |
| 2023 | $48.22M | +69.8% |
| 2022 | $28.40M | +9.9% |
| 2021 | $25.85M | - |